psychedelics

Documents about psychedelics

• Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.#631072NCBI PubMed Central
• Consciousness, Psilocybin, and Well-Being#897690ClinicalTrials.gov
• Age moderates the relationship between psychedelics use and mental health in naturalistic settings#4919Europe PMC
• Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.#224736NCBI PubMed Central
• Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically.#265546NCBI PubMed Central
• Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.#297141NCBI PubMed Central
• Parallel Claustral Networks for Behavioral Control in Health and Disease#313366OSF
• Can Psychedelics help with Alcohol Use Disorder (AUD): For now, the data says no.#630736NCBI PubMed Central
• Psilocybin-Assisted Therapy as a Treatment for Depression#854604ClinicalTrials.gov
• Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology.#13715NCBI PubMed Central
• Modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms.#122740NCBI PubMed Central
• The Use of Psychedelics in the Treatment of Adult ADHD: A Systematic and Mechanistic Review.#140882NCBI PubMed Central
• Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT(2A) receptor psychedelics from a transdiagnostic perspective.#148491NCBI PubMed Central
• Facing trauma under the influence of psychedelics: A phenomenological study with Nova rave survivors.#322794NCBI PubMed Central
• Characterizing non-hallucinogenic psychedelics beyond the head twitch response: phenotypic fingerprinting of lisuride and LSD.#472354NCBI PubMed Central
• Psilocybin use among Basotho healers and non-healers in southern Africa#126134OSF
• The contribution of psychotherapy in potential therapeutic effects of psychedelics for treatment of opioid use disorder.#317994NCBI PubMed Central
• Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.#380952NCBI PubMed Central
• Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks.#636518NCBI PubMed Central
• Psychedelics, rebirth experiences, and the limits of current research#665363HAL (France)
• Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use#74061PhilArchive
• Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.#135864NCBI PubMed Central
• Tending the Spiritual Workshops: Development, Evaluation, and Autoethnographic Assessment of Lessons Learned#233244OSF
• Altered States, Enhanced Potential: Psychedelics and Physical Performance#276595OSF
• Altered States, Enhanced Potential: Psychedelics and Physical Performance#276703OSF
• Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment‐Resistant Depression: A Qualitative Study.#288894NCBI PubMed Central
• EFFECT OF PSILOCYBIN ON PERSISTENT AVERSIVE SIGNALING ACROSS THE CINGULATE CORTEX#929314ScholarlyCommons
• How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence#92100PhilArchive
• Psychedelics do not always enhance cognitive flexibility: The potential role of time-varying effects on reward learning processes.#340569NCBI PubMed Central
• The Role of Perennialist Thought in the Development of Psychedelic Research in the United States#492182ScholarWorks@GSU
• Neural correlates and behavioral outcomes of aesthetic chills and their prosthetic augmentation#928143OSF
• The Emperor's New Diagnoses: Psychedelics, Psychosis, and the Limits of Psychiatric Distinctions#265819OSF
• Reimagining Neuropsychiatric and Neurological Disorders through the Lens of Brain Network Dynamics: Psychedelics as Catalysts for System-Level Plasticity.#309001NCBI PubMed Central
• The Adverse Effects and Therapeutic Potential of Psychedelic Medicines: A Guide to the Risks and Rewards of Using Psychedelics in Therapy#687510PhilArchive
• Traces of the Other – Are DMT Entities Real? DMT Phenomenology in the Framework of Conscious Realism#233239OSF
• A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety#840959ClinicalTrials.gov
• Koshering Psychedelics: Ayahuasca in the Ultra-Orthodox (Haredi) Jewish World#295827OSF
• Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects#807031ClinicalTrials.gov
• Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".#338647NCBI PubMed Central
• Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review#15412HAL (France)
• MDMA-Assisted Therapy for Social Anxiety Disorder: A Randomized, Open-label, Wait-list Controlled Trial#260563OSF
• Psilocybin Microdosing on Cognition, Mood and Quality of Life#888998ClinicalTrials.gov
• Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder#803370ClinicalTrials.gov
• MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial#994668ClinicalTrials.gov
• Psilocybin-assisted Therapy for Phantom Limb Pain#860107ClinicalTrials.gov
• A very brief review of the life and work of neuroscientist, physician, psychoanalyst, inventor, animal rights activist and pioneer in dolphins, isolation tanks and psychedelics John C Lilly 1915-2001.#753411PhilArchive
• Trifecta Research Study#980022ClinicalTrials.gov
• THIS IS YOUR BRAIN ON DRUGS: A MULTIMODAL NEUROIMAGING AND COMPUTATIONAL INVESTIGATION INTO THE EFFECTS OF PSYCHEDELIC TRYPTAMINES AND MDMA ON HUMAN BRAIN DYNAMICS#493404Cornell eCommons
• Factores Asociados a la Actitud de los Profesionales de la Salud Mental Hacia la Terapia Asistida con Psicodélicos: Una Revisión Sistemática.#663301PsyArXiv
• Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)#879368ClinicalTrials.gov